GeneBioTech Co. ,Ltd (KOSDAQ:086060)
3,925.00
-170.00 (-4.15%)
At close: May 29, 2026
GeneBioTech Co. ,Ltd Revenue
GeneBioTech Co. ,Ltd had revenue of 21.50B KRW in the quarter ending March 31, 2026, a decrease of -5.91%. This brings the company's revenue in the last twelve months to 89.44B, up 4.42% year-over-year. In the year 2025, GeneBioTech Co. ,Ltd had annual revenue of 90.79B with 9.44% growth.
Revenue (ttm)
89.44B
Revenue Growth
+4.42%
P/S Ratio
0.38
Revenue / Employee
2.13B
Employees
42
Market Cap
33.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 90.79B | 7.83B | 9.44% |
| Dec 31, 2024 | 82.96B | 3.48B | 4.38% |
| Dec 31, 2023 | 79.48B | -3.28B | -3.97% |
| Dec 31, 2022 | 82.76B | 19.94B | 31.75% |
| Dec 31, 2021 | 62.81B | 3.69B | 6.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korea Arlico Pharm | 199.14B |
| RP Bio | 136.22B |
| Korean Drug | 62.76B |
| ChoA Pharmaceutical Co., LTD. | 59.62B |
| Kyung Nam Pharm | 56.18B |
| Seoul Pharma | 51.33B |
| Eagle Veterinary Technology Co.,Ltd | 43.32B |
| Daesung Microbiological Labs. | 25.87B |